All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

← First12345...863Next →

hiv & aids news selected from other sources

  • Epidemiology
    Exclusive: North Korea claimed to be free of HIV. But infections appear to be surging
    Science | 6 hours ago

    If HIV infections continue to climb, North Korea could take draconian measures “to contain the disease at all costs,” Taehoon Kim warns. North Korean statutes permit the government to move ill people against their will or deport them, he notes.

  • Resistance
    Genotype Testing at HIV Diagnosis Provides No Benefit
    Infectious Disease Advisor | 6 hours ago

    For the majority of people with HIV in the US, the current treatment guidelines recommend an integrase strand inhibitor paired with an NRTI as first-line ART. Therefore, baseline genotype results currently guide the choice of initial NRTI pair, given transmitted NRTI resistance (NRTI-R). With this evolution of HIV treatment, the role and value of baseline genotype testing has become uncertain. This study determined the clinical and economic value of baseline genotype testing for people newly diagnosed with HIV in the US.

  • Support issues for children and young people
    How preschools can do more to support children living with HIV
    The Conversation | 6 hours ago

    Thanks to antiretroviral therapy, children living with HIV are likely to live much longer than they would without treatment. They will go to school like other children and develop in much the same way. But how much do their teachers and peers need to know about their HIV-positive status? And what is the best way of managing their particular health needs at preschool level?

  • Adherence
    Researchers Discuss Ethics and Privacy Concerns About the Growing Field of HIV Adherence Monitoring
    The Body Pro | 6 hours ago

    We have several ways to measure adherence to treatment or pre-exposure prophylaxis (PrEP). But as technology changes, and the fields of HIV medicine and public health focus increasingly on monitoring viral suppression or drug concentrations in the body for PrEP, the questions about the ethics of certain technologies, their uses, and what happens to that data are still being debated.

  • The search for a cure
    Disabling CCR5 Could Be Key to a Cure—but at What Cost?
    Poz | 6 hours ago

    Interfering with this receptor on immune cells could have harmful health consequences.

  • Long-acting HIV treatment
    Study Finds Long-Acting HIV Meds Are Acceptable to Many People, but Differences Exist Among Groups
    The Body Pro | 6 hours ago

    Now that long-acting antiretroviral therapy (LA-ART) is nearly a reality, is it something that people with HIV will prefer over once-daily pills? A study presented during a poster session at the International Conference on HIV Treatment and Prevention Adherence tried to find out whether LA-ART was as acceptable as daily-pill ART among 374 people living with HIV in a clinic in Houston. While they found that overall, LA-ART was acceptable among a majority of people, it wasn't equally acceptable among all groups.

  • Access to medicines and treatment
    Desperate patients turn to buyers clubs
    The Economist (free registration required) | 10 hours ago

    What do you do when the NHS won’t buy the treatment you need?

  • People and personal stories
    Elton John awarded France's highest civilian award Legion d'Honneur
    BBC News | 11 hours ago

    The British musician was presented with the award by President Emmanuel Macron during a ceremony at the Élysée Palace. President Macron's office praised Sir Elton, 72, as a "melodic genius" and as one of the first gay artists to give a voice to the LGBT community. He used his acceptance speech to promote his charity work.

  • PrEP policies and guidelines
    US: Senate Bill Proposes Expansion of PrEP Access
    Pharmacy Times | 11 hours ago

    A bill introduced by Senator Kamala Harris (D-CA) Thursday, the PrEP Access and Coverage Act, would expand access to pre-exposure prophylaxis (PrEP), medications that can reduce the risk of HIV infection by up to 92%.

  • Side-effects
    Major HIV drug calls for vigilance
    University of Duisberg-Essen | 23 hours ago

    A study lead by researchers at the Institute of HIV Research, Medical Faculty of UDE and University Hospital Essen, stumbled over a potential toxicity of integrase inhibitors. The researchers found that INSTI had a dramatic effect on activity of immune cells and in particular reduced the activity and function of CD4 T helper cells. This included a reduced proliferation and multiplication of these cells.

← First12345...12Next →

Conference news

News from the 25th Annual Conference of the British HIV Association (BHIVA).

EUROBulletin

Sign up for our Sexual Health & HIV Policy EUROBulletin.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

aidsmapLIVE

Watch our AIDS 2018 aidsmapLIVE panel discussion on YouTube.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.